Quality-by-Design-Based Development and Optimization of Emtricitabine-Loaded Solid Lipid Nanoparticles

Shubhrat Maheshwari; Aditya  Singh; Amita  Verma

doi:10.22270/jddt.v16i8.7946

Authors

Shubhrat Maheshwari Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj, 211007, India. https://orcid.org/0000-0002-2677-4229
Aditya Singh Department of Pharmaceutics, Parul Institute of Pharmacy & Research, Parul University, Waghodia, Vadodara – 391760, Gujarat, India. https://orcid.org/0000-0002-0398-6130
Amita Verma Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj, 211007, India. https://orcid.org/0000-0001-6653-7335

Abstract

Background: Emtricitabine (FTC) is a nucleoside reverse transcriptase inhibitor widely used in combination antiretroviral therapy for HIV infection. Its pharmacokinetic characteristics and need for regular dosing may affect patient adherence. Solid lipid nanoparticles (SLNs) have been considered beneficial in terms of drug entrapment and drug delivery. The study was conducted using a Quality-by-Design (QbD) strategy along with Box–Behnken Design (BBD) in order to optimize FTC-loaded SLNs systematically.

Methods: A three-variable, three-level Box-Behnken Design consisting of seventeen runs has been employed to investigate the effects of stearic acid concentration, Tween 80 concentration, and homogenization speed on the entrapment efficiency of FTC.

Results: The optimized quadratic model exhibited exceptional predictive ability (R² =0.9989, adjusted R² = 0.9976, predicted R² = 0.9867), along with a non-significant lack of fit (p = 0.1047). It was found that stearic acid had the highest positive effect on EE%, while an increase in Tween 80 concentration and homogenization speed reduced the drug entrapment significantly. Results from the numerical optimization indicated that the optimized formulation had 164.68 mg of stearic acid, 2.09% of Tween 80 concentration, and a homogenization speed of 12,074.8 rpm, which yielded an EE% of 85.32%. Experimental validation indicated an EE% of 85.28%, which matched quite closely with the predicted value, yielding a prediction bias of 0.047%.

Conclusion: The QbD-driven BBD method developed a reliable and statistically valid optimization method for SLNs loaded with FTC. The optimization study provided an effective formulation with high entrapment efficiency and corroborated the reliability of the approach employed, leading to promising possibilities for the physical and chemical characterization, controlled release assessment, and future reproduction of emtricitabine-loaded lipid formulations.

Keywords – Emtricitabine[FTC]; Solid lipid Nanoparticles[SLNs]; Quality by Design[QbD]; Entrapment efficiency; Box-Behnken design [BBD]; Nanocarrier optimization.

Keywords:

Emtricitabine[FTC], Solid lipid Nanoparticles[SLNs], Quality by Design[QbD], Entrapment efficiency, Box Behnken design [BBD], Nanocarrier optimization

DOI

https://doi.org/10.22270/jddt.v16i8.7946

Author Biographies

Shubhrat Maheshwari, Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj, 211007, India.

Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj, 211007, India.

Aditya Singh , Department of Pharmaceutics, Parul Institute of Pharmacy & Research, Parul University, Waghodia, Vadodara – 391760, Gujarat, India.

Department of Pharmaceutics, Parul Institute of Pharmacy & Research, Parul University, Waghodia, Vadodara – 391760, Gujarat, India.

Amita Verma , Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj, 211007, India.

Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj, 211007, India.

References

1. Peng, Y., Zong, Y., Wang, D., Chen, J., Chen, Z. S., Peng, F., & Liu, Z. Current drugs for HIV-1: from challenges to potential in HIV/AIDS. In Frontiers in Pharmacology, Frontiers Media SA. 2023;14. https://doi.org/10.3389/fphar.2023.1294966

2. Al-Majed, A. A., Bakheit, A. H. H., Al-Qahtani, B. M., Al-Kahtani, H. M., & Abdelhameed, A. S. (2020). Emtricitabine. Profiles of Drug Substances, Excipients and Related Methodology, 45, 55–91. https://doi.org/10.1016/BS.PODRM.2019.10.003

3. Deeks, E. D. (2014). Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Review of Its Use in HIV Infection. Drugs 2014 74:17, 74(17), 2079–2095. https://doi.org/10.1007/S40265-014-0318-1

4. Mandal, S., Belshan, M., Holec, A., Zhou, Y., & Destache, C. J. An enhanced emtricitabine-loaded long-acting nanoformulation for prevention or treatment of HIV infection. Antimicrobial Agents and Chemotherapy, 2017;61(1). https://doi.org/10.1128/AAC.01475-16

5. Dhiman, S., Singh, T. G., Anand, S., & Yadav, P. Formulation and Evaluation of Solid Lipid Nanoparticles for controlled delivery of Zidovudine. Research Journal of Pharmacy and Technology, 2021;14(5):2548–2556. https://doi.org/10.52711/0974-360X.2021.00449

6. Gaur, P. K., Mishra, S., Bajpai, M., & Mishra, A. Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies. BioMed Research International, 2014. https://doi.org/10.1155/2014/363404

7. Bukke, S. P. N., Venkatesh, C., Bandenahalli Rajanna, S., Saraswathi, T. S., Kusuma, P. K., Goruntla, N., Balasuramanyam, N., & Munishamireddy, S. Solid lipid nanocarriers for drug delivery: design innovations and characterization strategies—a comprehensive review. In Discover Applied Sciences. Springer Nature. 2024;6(6). https://doi.org/10.1007/s42452-024-05897-z

8. ICH Official web site : ICH. (n.d.). Retrieved July 29, 2026, from https://www.ich.org/page/quality-guidelines?utm_source=

9. Yu, L. X., Amidon, G., Khan, M. A., Hoag, S. W., Polli, J., Raju, G. K., & Woodcock, J. Understanding Pharmaceutical Quality by Design. The AAPS Journal, 2014;16(4):771. https://doi.org/10.1208/S12248-014-9598-3

10. Grangeia, H. B., Silva, C., Simões, S. P., & Reis, M. S. Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives. European Journal of Pharmaceutics and Biopharmaceutics, 2020;147:19–37. https://doi.org/10.1016/j.ejpb.2019.12.007

11. Pramod, K., Tahir, M. A., Charoo, N. A., Ansari, S. H., & Ali, J. Pharmaceutical product development: A quality by design approach. International Journal of Pharmaceutical Investigation, 2016;6(3):129. https://doi.org/10.4103/2230-973X.187350

12. Beg, S., & Akhter, S. Box–Behnken Designs and Their Applications in Pharmaceutical Product Development. Design of Experiments for Pharmaceutical Product Development Volume I: Basics and Fundamental Principles, 2021;1:77–85. https://doi.org/10.1007/978-981-33-4717-5_7/SAVE-RESEARCH

13. Szpisják-Gulyás, N., Al-Tayawi, A. N., Horváth, Z. H., László, Z., Kertész, S., & Hodúr, C. Methods for experimental design, central composite design and the Box–Behnken design, to optimise operational parameters: A review. Acta Alimentaria, 2023;52(4):521–537. https://doi.org/10.1556/066.2023.00235

14. Waghule, T., Dabholkar, N., Gorantla, S., Rapalli, V. K., Saha, R. N., & Singhvi, G. Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach. Biomedicine & Pharmacotherapy, 2021;141:111940. https://doi.org/10.1016/J.BIOPHA.2021.111940

15. Kamankar, S., Jain, N., Jain, U., Aher, S., Kamankar, S., Jain, N., Jain, U., Aher, S., Kamankar, S., Jain, N., Jain, U., & Aher, S. (2026). Application of Quality by Design (QbD) in the Formulation & Process Optimization of Nanoparticles for Targeted Drug Delivery Systems: A Comprehensive Review. International Journal of Scientific Research and Technology, 03(07), 395–409. https://doi.org/10.5281/ZENODO.21376541

16. Amasya, G., Aksu, B., Badilli, U., Onay-Besikci, A., & Tarimci, N. (2019). QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment. International Journal of Pharmaceutics, 563, 110–121. https://doi.org/10.1016/J.IJPHARM.2019.03.056

17. Mercuri, A. M. (2016). Quality by Design Applied to Ocular Solid Lipid Nanoparticles Containing a Hydrophilic Peptide Prepared via Hot High Pressure Homogeniser. Current Drug Delivery, 13(8), 1247–1260. https://doi.org/10.2174/1567201813666160325131831

18. Krishna Veni, D., & Gupta, N. V. (2019). Quality by design approach in the development of solid lipid nanoparticles of linagliptin. Research Journal of Pharmacy and Technology, 12(9), 4454–4462. https://doi.org/10.5958/0974-360X.2019.00768.6

19. Sri Rekha, M., & Sangeetha, S. (2024). Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box-Behnken Design for Boosting Oral Bioavailability. Advances in Pharmacological and Pharmaceutical Sciences, 2024(1). https://doi.org/10.1155/2024/5248746

20. Aparicio-Blanco, J., Martín-Sabroso, C., Fernandez-Carballido, A., Katona, G., Sipos, B., & Csóka, I. (2022). Risk-Assessment-Based Optimization Favours the Development of Albumin Nanoparticles with Proper Characteristics Prior to Drug Loading. Pharmaceutics 2022, Vol. 14, Page 2036, 14(10), 2036. https://doi.org/10.3390/PHARMACEUTICS14102036

21. Iurian, S., Turdean, L., & Tomuta, I. (2017). Risk assessment and experimental design in the development of a prolonged release drug delivery system with paliperidone. Drug Design, Development and Therapy, 11, 733–746. https://doi.org/10.2147/DDDT.S125323

22. Bhalekar, M., Upadhaya, P., & Madgulkar, A. Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavir. Applied Nanoscience 2017 7:1, 7(1), 47–57. https://doi.org/10.1007/s13204-017-0547-1

23. SHAH, V. A., & PATEL, J. K. (2021). OPTIMIZATION AND CHARACTERIZATION OF DOXORUBICIN LOADED SOLID LIPID NANOSUSPENSION FOR NOSE TO BRAIN DELIVERY USING DESIGN EXPERT SOFTWARE. International Journal of Pharmacy and Pharmaceutical Sciences, 45–57. https://doi.org/10.22159/ijpps.2021v13i5.41137

24. Raina, H., Kaur, S., & Jindal, A. B. (2017). Development of efavirenz loaded solid lipid nanoparticles: Risk assessment, quality-by-design (QbD) based optimisation and physicochemical characterisation. Journal of Drug Delivery Science and Technology, 39, 180–191. https://doi.org/10.1016/J.JDDST.2017.02.013

25. Sri Rekha, M., & Sangeetha, S. (2024). Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box–Behnken Design for Boosting Oral Bioavailability. Advances in Pharmacological and Pharmaceutical Sciences, 2024(1), 5248746. https://doi.org/10.1155/2024/5248746

26. Parhi, R., & Suresh, P. (2012). Preparation and Characterization of Solid Lipid Nanoparticles-A Review. Current Drug Discovery Technologies, 9(1), 2–16. https://doi.org/10.2174/157016312799304552/CITE/REFWORKS

27. Cortial, A., Vocanson, M., Loubry, E., & Briançon, S. Hot homogenization process optimization for fragrance encapsulation in solid lipid nanoparticles. Flavour and Fragrance Journal, 2015;30(6):467–477. https://doi.org/10.1002/FFJ.3259

28. Siddiqua Gazi, A., & Krishnasailaja, A. (2018). Preparation & evaluation of paracetamol solid lipid nanoparticles by hot homogenization method. https://doi.org/10.15406/jnmr.2018.07.00184

29. Shelke, A., Surwae, P., Bendale, A. R., Borse, L., & Jadhav, A. G. Method stability indicating method development and validation for emtricitabina by UV spectroscopic and RP-HPLC methods. International Journal of Pharmaceutical Chemistry and Analysis, 2022;9(1):10–16. https://doi.org/10.18231/j.ijpca.2022.002

30. Shelke, A., Shinde, M., Mogal, R., Sable, R., & Jadhav, Dr. A. Application of UV Spectrophotometric Methods for Simultaneous Estimation of Emtricitabine and Tenofovir Alafenamide Fumarate in Bulk. Asian Journal of Pharmacy and Technology, 2018;8(2):103–107. https://doi.org/10.5958/2231-5713.2018.00016.8

31. Rohit, B., & Pal, K. I. A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs. Current Nanoscience, 2013;9(2):211–220. https://doi.org/10.2174/1573413711309020008

32. Singh, S., Dobhal, A. K., Jain, A., Pandit, J. K., & Chakraborty, S. Formulation and Evaluation of Solid Lipid Nanoparticles of a Water Soluble Drug: Zidovudine. Chemical and Pharmaceutical Bulletin, 2010;58(5):650–655. https://doi.org/10.1248/CPB.58.650